Cargando…
Fractalkine/CX(3)CR(1) Pathway in Neuropathic Pain: An Update
Injuries to the nervous system can result in a debilitating neuropathic pain state that is often resistant to treatment with available analgesics, which are commonly associated with several side-effects. Growing pre-clinical and clinical evidence over the last two decades indicates that immune cell-...
Autores principales: | Silva, Rita, Malcangio, Marzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915718/ https://www.ncbi.nlm.nih.gov/pubmed/35295489 http://dx.doi.org/10.3389/fpain.2021.684684 |
Ejemplares similares
-
Fractalkine/CX3CR1 signaling during neuropathic pain
por: Clark, Anna K., et al.
Publicado: (2014) -
Fractalkine/CX3CR1 Contributes to Endometriosis-Induced Neuropathic Pain and Mechanical Hypersensitivity in Rats
por: Liu, Zhiming, et al.
Publicado: (2018) -
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain
por: Zhu, Wenjun, et al.
Publicado: (2013) -
Dorsal root ganglia CX3CR1 expressing monocytes/macrophages contribute to arthritis pain
por: Oggero, Silvia, et al.
Publicado: (2022) -
EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
por: Gazerani, P, et al.
Publicado: (2014)